Wrinkles aren’t just a sign of ageing on our appearance, but also occurs deep inside on a cellular level. These wrinkles appear to prevent our genes from functioning properly, researchers have found.
A new method can examine protein assembly in real time, in living cells, to find problems in the process and diagnose the resulting diseases, according to new research.
A research team has identified the essential role of a structural protein in the silencing of the inactive X chromosome, a process that prevents both copies of the same gene from being expressed in female mammals, which carry two copies of the X chromosome.
Researchers have discovered that tumour cells reprogram metabolic pathways to gain control over a type of immune cell that allows cancer growth.
Recent scientific studies have claimed that transfusions of blood from teenagers can help delay or reverse the ageing process. Do they stack up?
Researchers have synthesized the first artificial human prion, a dramatic development in efforts to combat a devastating form of brain disease that has so far eluded treatment and a cure.
The genomes of more than 3000 of these bacteria have been mapped by scientists in order to better understand diseases and the mechanisms of antibiotic resistance.
New findings suggest that a person’s own immune system helps nudge him or her down the path toward Parkinson’s, and that restraining the immune system with drugs potentially could prevent the neurological disorder.
A GRAIL funded study shows that a liquid biopsy approach might be able to detect early-stage lung cancer.
Researchers have uncovered some of the genetic changes that explain how our brains got so big.
Starting about 7,000 years ago, and extending over the next two millennia, recent studies suggest, the genetic diversity of men—specifically, the diversity of their Y chromosomes—collapsed.
Interested in novel science and its applications, but sick to death of hearing about CRISPR? Then this story is for you.
New biotechnology could speed up the development of medicines to treat pulmonary fibrosis, one of the most common and serious forms of lung disease, research shows.
Japanese scientists now have permission to treat people who have heart disease with cells produced by a revolutionary reprogramming technique, which excites researchers. But some fear the therapy will be rushed to market.
Myriad Genetics has revealed it is acquiring genetic screening firm Counsyl for $375 million.
